Results for tag: "Glucosylceramidase"

Glucosylceramidase is an enzyme that catalyzes the hydrolysis of glucosylceramide, a type of glycolipid found in the cell membrane of many organisms. It is involved in the degradation of glycosphingolipids, which are important components of the cell membrane. Glucosylceramidase is used in the treatment of Gaucher's disease, a rare genetic disorder caused by the accumulation of glucosylceramide in the lysosomes of cells. It is also used in the diagnosis of other lysosomal storage diseases. The glucosylceramidase market is driven by the increasing prevalence of Gaucher's disease and other lysosomal storage diseases, as well as the growing demand for enzyme replacement therapy. The market is further supported by the increasing number of clinical trials and research activities related to glucosylceramidase. Some companies in the glucosylceramidase market include Sanofi, Pfizer, Shire, and Genzyme. Show Less Read more